Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets

Article Tools

• Email

  Thank you for your interest in spreading the word about Science Signaling.

  NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

  Your Email

  Your Name

  Send To

  Enter multiple addresses on separate lines or separate them with commas.

  You are going to email the following Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets

  Message Subject (Your Name) has forwarded a page to you from Science Signaling

  Message Body (Your Name) thought you would like to see this page from the Science Signaling web site.

  Your Personal Message

  CAPTCHA

  This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

  Send Message
• Download Powerpoint
• Print
• Alerts

  Please log in to add an alert for this article.

  Log In with your AAAS ID

  Sign In to Email Alerts with your Email Address

  Email

  Log in
• Citation tools

  Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets

  By Martin L. Miller, Evan J. Molinelli, Jayasree S. Nair, Tahir Sheikh, Rita Samy, Xiaohong Jing, Qin He, Anil Korkut, Aimee M. Crago, Samuel Singer, Gary K. Schwartz, Chris Sander

  Science Signaling24 Sep 2013 : ra85

  Drug screening and computational modeling of oncogenic signaling pathways identifies synergistic drug pairs for liposarcoma.

  • Supplementary Materials

  Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
• Share

  Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets

  By Martin L. Miller, Evan J. Molinelli, Jayasree S. Nair, Tahir Sheikh, Rita Samy, Xiaohong Jing, Qin He, Anil Korkut, Aimee M. Crago, Samuel Singer, Gary K. Schwartz, Chris Sander

  Science Signaling24 Sep 2013 : ra85

  Drug screening and computational modeling of oncogenic signaling pathways identifies synergistic drug pairs for liposarcoma.

  • Supplementary Materials

  Share This Article: Copy